Drug-Supplement Interactions: An Overview
Date: 5/13/2019 - 5/13/2022
|NPTA Elite: Included With Membership||Register
|NPTA CE+: Included With Membership||Register
|NPTA Insider: $12.50||Register
Contact Hours: 3.0
ACPE UAN: 0384-9999-19-107-H01-T
The National Pharmacy Technician Association (NPTA) is accredited by the Accreditation Council for
Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Target Audience: Certified Pharmacy Technicians
This CPE activity has been designated as a knowledge-based program.
Author: Phillip Gregory Pharm D
Faculty Disclosures/Conflicts of Interest: Author declared no conflict of interest and all information is provided fairly and without bias. Author received no commercial/financial support for this activity and do not approve or endorse any commercial products displayed.
Goals & Objectives:
At the completion of this activity, participants should be able to:
- Define the term “dietary supplement.”
- Describe the regulatory status of dietary supplement in the United States.
- Describe the prevalence of dietary supplement use in the United States.
- List determinants of dietary supplement use.
- List risk factors for drug-supplement interactions.
- List risk factors for major drug-supplement interactions.
- Identify potential pharmacodynamic interactions between dietary supplements and drugs.
- Identify potential pharmacokinetic interactions between dietary supplements and drug.
- List dietary supplements that have the potential to interact with warfarin.
- Describe the effect of St. John’s wort on drugs metabolized by cytochrome P450 3A4.
- Describe steps that can be taken to reduce the risk of potential drug-supplement interactions.
Release Date: 05/13/2019
Expiration Date: 05/13/2022